UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES  

PURSUANT TO SECTION 12(b) OR (g) OF THE  

SECURITIES EXCHANGE ACT OF 1934

 

ShockWave Medical, Inc. 

(Exact name of registrant as specified in its charter)

 

Delaware		27-0494101
(State of incorporation or organization)		(I.R.S. Employer Identification No.)
5403 Betsy Ross Drive Santa Clara, California		95054
(Address of principal executive offices)		(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be so registered		Name of each exchange on which each class is to be registered
Common Stock, par value $0.001 per share		The Nasdaq Stock Market LLC (Nasdaq)

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. þ 

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. 

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box.  

 

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333- 229590

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1.

Description of Registrant’s Securities to be Registered.

A description of the registrant’s common stock, par value $0.001 per share, registered hereby is set forth under the caption “Description of Capital Stock” in the registrant’s registration statement on Form S-1 (File No. 333-229590) filed with the Securities and Exchange Commission on February 8, 2019, as thereafter amended (the “Registration Statement”), which is incorporated herein by reference. Any prospectus that constitutes part of the Registration Statement and is filed by the registrant pursuant to Rule 424(b) under the Securities Act of 1933 shall be deemed incorporated herein by reference.

 

Item 2.

Exhibits.

Not applicable.

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Dated: March 5, 2019						ShockWave Medical, Inc. (Registrant)
						By:		/s/ Dan Puckett
						Name:		Dan Puckett
						Title:		Chief Financial Officer and Secretary